Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
351
datasets available to search
ShareScore release 0.9.0
Dataset results
351 results for “empagliflozin”
Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients
ClinicalTrials.gov study NCT06483074. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin for the Treatment of Postprandial Hypoglycemia
ClinicalTrials.gov study NCT05036317. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Empagliflozin on Body Composition and Ketones
ClinicalTrials.gov study NCT03877406. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Empagliflozin as a Novel Therapy in Refractory Ascites
ClinicalTrials.gov study NCT05430243. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
ClinicalTrials.gov study NCT07093476. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Empagliflozin as Adjuvant Therapy in Patients With Ulcerative Colitis
ClinicalTrials.gov study NCT05058417. IPD Sharing: YES. Countries: 1. Publications: 0.
Empagliflozin Reversal of Arterial StiffnEss in Aging
ClinicalTrials.gov study NCT06506422. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin in Adolescent Diabetes
ClinicalTrials.gov study NCT04917692. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT
ClinicalTrials.gov study NCT06818305. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin
ClinicalTrials.gov study NCT06571591. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Empagliflozin in Acute Heart Failure
ClinicalTrials.gov study NCT05305495. IPD Sharing: NO. Countries: 1. Publications: 0.
The Impact of Genetic Polymorphism on the Echocardiographic Parameters and Cardiac Fibrosis Markers in Response to Empagliflozin Treatment Among Patients With Heart Failure
ClinicalTrials.gov study NCT06503601. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Acute Effect of Empagliflozin vs Dapagliflozin Over Pulse Wave Velocity in Type Two Diabetes
ClinicalTrials.gov study NCT05109949. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin to Prevent Post-Operative Atrial Fibrillation
ClinicalTrials.gov study NCT06124937. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
ClinicalTrials.gov study NCT06554301. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin in Heart Failure Dialysis Patients
ClinicalTrials.gov study NCT05967156. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Glycemic Control with Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination
ClinicalTrials.gov study NCT06862739. IPD Sharing: NO. Countries: 0. Publications: 0.
Bioequivalence Study of Empagliflozin Tablet in Healthy Participants.
ClinicalTrials.gov study NCT03771781. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/850 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy® 5 mg/850 mg Film-coated Tablets (Boeh
ClinicalTrials.gov study NCT06766500. IPD Sharing: NO. Countries: 1. Publications: 0.
Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate Levels
ClinicalTrials.gov study NCT06284850. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.